Mandate

Vinge advises BHG Group in acquisition of Nordic Nest

December 14, 2020 Employment and Benefits M&A

Vinge is advising BHG Group AB (publ) in connection with the acquisition of 97.6 per cent of the shares in Nordic Nest Group AB. The acquisition price corresponds to an enterprise value of SEK 1.8 billion.

Nordic Nest offers Scandinavian home decoration design online with customers in 70 countries, including the Nordics, Germany and South Korea. The company has approximately 220 employees and for the split fiscal year 2020/21, which ends on 31 March 2021, net sales are expected to be approximately SEK 1 billion and EBITDA is expected to amount to approximately MSEK 120.

BHG is the largest online actor within consumer trading in the Nordics and the largest actor in Europe within Home improvement, which includes both Do-It-Yourself and Home Furnishings. BHG’s e-trading business has 1,800 employees and includes more than 85 online destinations. The head office is situated in Malmö and the company conducts operations in most European countries. BHG is listed on Nasdaq Stockholm.

 

Vinge’s team consists of Kristian Ford together with, among others, Pär Remnelid, Philip ÅbergTilda HallDaniel Melander Björner and Emelie Svensäter Jerntorp.

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025